MedPath

Nutrition and Pregnancy Intervention Study

Not Applicable
Completed
Conditions
Pregnancy
Cardiovascular Risk Factor
Obesity
Neurodevelopmental Disorders
Adiposity
Eating Behavior
Liver Diseases
Cognitive Developmental Disorders
Gestational Diabetes Mellitus
Type2 Diabetes
Interventions
Dietary Supplement: Comparison of probiotics, fish oil and their combination to placebo
Registration Number
NCT01922791
Lead Sponsor
Turku University Hospital
Brief Summary

A randomized double-blind placebo controlled intervention study with pregnant obese women (n=440) will be conducted. The intervention will involve consumption of fish oil and/or probiotic capsules from early pregnancy until 6 months after delivery.

The aim of the study is firstly to investigate the effects of the supplements on the risk of gestational diabetes mellitus and obesity in the women and secondly to modify the risk markers of allergy and obesity in children of the women. Also the underlying metabolic mechanisms will be investigated.

Follow up visits at child's age of 5 to 6 years will be conducted to evalute long-term effects on maternal and child health. The aim is to investigate the impact of dietary intervention, diet, maternal overweight/obesity and gestational diabetes status as well as gut microbiota and metabolism during pregnancy on maternal and child's health, allergy and child neuropsychological development.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
439
Inclusion Criteria
  • pregnant, less than 17 gestational weeks
  • overweight
  • healthy
Exclusion Criteria
  • Diabetes (type 1 or 2)
  • Coeliac disease
  • Increased bleeding tendency

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fish oilComparison of probiotics, fish oil and their combination to placeboComparison of probiotics, fish oil and their combination to placebo
Probiotics and Fish oilComparison of probiotics, fish oil and their combination to placeboComparison of probiotics, fish oil and their combination to placebo
ProbioticComparison of probiotics, fish oil and their combination to placeboComparison of probiotics, fish oil and their combination to placebo
PlaceboComparison of probiotics, fish oil and their combination to placeboComparison of probiotics, fish oil and their combination to placebo
Primary Outcome Measures
NameTimeMethod
Prevalence of gestational diabetes mellitus, GDMAssessed at gestational weeks 24-28
Fasting glucose levelsassessed at the third trimester of pregnancy
Prevalence of allergy in childassessed at 12 and 24 months of age
Secondary Outcome Measures
NameTimeMethod
Social emotional assessment by Behavior Rating Inventory of Executive Functions (child)Assessed at 5-6 yrs postpartum
Fecal microbiotaBefore, during and after intervention
Fasting serum glucose (mmol/l) (mother/ child)Assessed at 5-6 years postpartum
Immunologic and metabolic markersDuring and after pregnancy
Need for medication for management of gestational diabetes mellitus GDM (insulin or metformin)During pregnancy
Body composition of motherDuring and after pregnancy
Fasting serum insulin (mU/l) (mother/child)Assessed at 5-6 years postpartum
Number of women with prediabetes using criteria defined by American Diabetes AssociationAssessed at 5-6 years postpartum
Number of women with metabolic syndrome using criteria defined by The International Diabetes FederationAssessed at 5-6 yrs postpartum
Risk for Type 2 diabetes using questionnaire (mother)Assessed at 5-6 yrs postpartum
Serum high sensitive C-reactive protein (mg/l) (mother/child)Assessed at 5-6 yrs postpartum
Lipid metabolism (fasting cholesterol (mmol/l), fasting triglycerides (mmol/l), fasting HDL-cholesterol (mmol/l), fasting LDL-cholesterol (mmol/l) (mother/child)Assessed at 5-6 yrs postpartum
Serum metabolomics by NMR (mother/child)assessed at 5-6 yrs postpartum
Liver fat by ultra sound (mother)Assessed at 5-6 yrs postpartum
Liver health by ALAT (child/mother)Assessed at 5-6 yrs postpartum
Fecal microbiota composition (mother/child)Assessed at 5-6 yrs postpartum
Dietary intake of foods and nutrients and diet pattern calculated from food diaries, dietary quality index and food frequencies (assessed by questionnaires)/mother and childAssessed at 5-6 yrs postpartum
Eating behavior by Three Factor Eating Questionnaire, Neofobia and Comprehensive Feeding Practices Questionnaire, Child Feeding Questionnaire, Child Eating Behaviour Questionnaire (child)Assessed at 5-6 yrs postpartum
Motor development by Movement Assessment Battery for Children and by Developmental Coordination Disorder Questionnaire 2007 (DCDQ'07) (Child)Assessed at 5-6 yrs postpartum
Cognitive development by Cantab test and Wechsler Preschool and Primary Scale of Intelligence (child)Assessed at 5-6 yrs postpartum
Obesity by body mass index (mother/child) and body fat percentage by air displacement plethysmography (mother/child)Assessed at 5-6 yrs postpartum
Carotid intima media thickness by ultra sound (mother/child)Assessed at 5-6 yrs postpartum
Retinal microvasculature by digital retinal imaging (mother)Assessed at 5-6 yrs postpartum
Child effortful/emotionally-driven inhibition by the Forbidden Toy task and by Delay of gratification test (child)Assessed at 5-6 yrs postpartum
The child's social competence by Multisource Assessment of Children's Social Competence questionnaire and children's behavioral, social, and attention problems by the Child Behavior Checklist. (child)Assessed at 5-6 yrs postpartum
Infant temperament, Child Behavior Questionnaire (child)Assessed at 5-6 yrs postpartum
Child growth measured from weight (kg) and length (cm)Assessed at 5-6 yrs postpartum
Atopy by serum antigens and asthma by spirometry (child)Assessed at 5-6 yrs postpartum
Immunological cells from blood (child)Assessed at 5-6 yrs postpartum
Physical activity by questionnaires and activity monitorAssessed at 5-6 yrs postpartum

Trial Locations

Locations (2)

University of Turku

🇫🇮

Turku, Finland

Turku University Hospital

🇫🇮

Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath